nineteen patients with predominantly intermediate gleason grade untreated stage a2 carcinomas of the prostate were studied by the unlabeled antibody immunoperoxidase technique for prostate-specific acid phosphatase and prostate-specific antigen in an attempt to identify those in whom the disease would progress without further therapeutic intervention .
C0600139
carcinomas of the prostate
C0138741
prostate-specific antigen